Peter Ottsjö is a tech journalist and author of the popular science book Evigt Ung (Forever Young), CEO of LEVITY Media Group and co-host of the LEVITY Podcast, Longevity Biotech Fellowship fellow and Vitalist.
Apr 12, 2026
•
15 min read
Plus: an AI that reads heart fat predicts failure five years out, Medra opens America's largest autonomous lab, and Genentech tests AI agents on 100 biology tasks.
Apr 10, 2026
13 min read
Amy Webb's Convergence Outlook devotes two of ten convergences to AI × bio. I read the 40+ pages so you don't have to.
Apr 9, 2026
12 min read
Plus: An AI designed enzymes for chemistry nature never invented, and a new study shows AlphaFold reversed a long-running decline in scientific novelty.
Apr 5, 2026
Plus: A massive AI model predicts aging and a paper says AI can replace biological clocks.
Apr 2, 2026
9 min read
A Johns Hopkins professor says AI in biology is starting to look like pseudoscience. Here's what covering 60+ stories in the past six weeks have taught us.
14 min read
Plus: three ex-Ginkgo leaders argue biology needs its Bauhaus moment, and the LabOS team builds a simulation universe for AI agents.
Mar 30, 2026
Plus: Meta open-sources a digital model of the brain, an AlphaFold veteran's agent designs drugs from a text prompt, and Anthropic may be building a biology mode.
Mar 25, 2026
Plus: A $787 million AI biologics company emerges, and a multi-agent AI for dementia validated across 3 million patients.
Mar 22, 2026
Plus: The field's own reality check, and experts preferred BioReason-Pro's reasoning over curated databases.
Mar 18, 2026
16 min read
Plus: NVIDIA breaks the size ceiling on protein folding, a million AI-designed proteins get tested in actual wet labs, and OpenClaw gets a science layer.
Mar 15, 2026
Plus: Nature Biotechnology maps the agentic AI boom, a YC startup's DNA sequences get slammed by a Stanford scientist, and MedOS heads to GTC.
Mar 11, 2026
11 min read
Plus: A complete cell cycle, simulated in six days on a supercomputer.
Mar 8, 2026
Plus: AI enters the operating room with FDA approval, and Insilico ships a drug discovery model that runs behind your firewall.
Mar 5, 2026
Plus: AI smart glasses are training junior scientists to expert level in a week
Mar 1, 2026
Plus: The largest biotech IPO since 2024 is built on generative protein design.
Feb 25, 2026
10 min read
Plus: Anthropic's cheap model catches up on biology and Lilly publishes its autonomous drug discovery framework.
Feb 15, 2026
7 min read
Bo Wang's lab built a cardiac world model that generalizes to new patients with almost no labeled data.
Feb 12, 2026
Isomorphic and Terray both outperform the leading open-source model - using opposite approaches. Plus: GPT-5 runs 36,000 lab experiments.
